Preclinical Assessment in Juvenile Sheep of an Allogeneic Bone Tissue Engineering Product with Wharton’s Jelly Mesenchymal Stromal Cells

Secondary osteonecrosis (ON) is a common complication in paediatric cancer survivors. Combining multipotent mesenchymal stromal cells (MSCs) with core decompression surgery halts disease progression and stimulates bone regeneration. However, the success of advanced therapy medicinal products (ATMPs)...

Full description

Saved in:
Bibliographic Details
Main Authors: Raquel Cabrera-Pérez, Irene Carreras-Sánchez, Ángela Roig-Molina, Alba López-Fernández, Irene Portas-Torres, Laura Batlle-Morera, Roberto Vélez, Joaquim Vives
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/14/12/862
Tags: Add Tag
No Tags, Be the first to tag this record!